A detailed history of Ever Source Wealth Advisors, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,277 shares of RGNX stock, worth $15,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,277
Previous 294 334.35%
Holding current value
$15,758
Previous $2,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$5.31 - $10.4 $5,219 - $10,223
983 Added 334.35%
1,277 $10,000
Q1 2025

May 13, 2025

BUY
$5.92 - $8.7 $1,669 - $2,453
282 Added 2350.0%
294 $2,000
Q4 2024

Feb 07, 2025

BUY
$7.23 - $11.56 $86 - $138
12 New
12 $0
Q2 2022

Aug 01, 2022

SELL
$19.35 - $35.04 $1,354 - $2,452
-70 Closed
0 $0
Q1 2022

May 25, 2022

BUY
$24.62 - $34.31 $1,723 - $2,401
70 New
70 $2,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $533M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.